Ticker Scorecard - CTMX Basics Company: CytomX Therapeutics, Inc. IPO Date: October 8, 2015 Sector: Healthcare Industry: Biotech Market Cap: $67.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 2.87% Avg Daily Range (30 D): $0.03 | 3.44% Avg Daily Range (90 D): $0.03 | 3.29% Institutional Daily Volume Avg Daily Volume: .69M Avg Daily Volume (30 D): .85M Avg Daily Volume (90 D): .98M Trade Size Avg Trade Size (Sh.): 176 Avg Trade Size (Sh.) (30 D): 388 Avg Trade Size (Sh.) (90 D): 376 Institutional Trades Total Inst.Trades: 814 Avg Inst. Trade: $1.44M Avg Inst. Trade (30 D): $1.1M Avg Inst. Trade (90 D): $1.1M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.6M Avg Closing Trade (30 D): $.52M Avg Closing Trade (90 D): $.52M Avg Closing Volume: 167.91K     News Jun 17, 2024 @ 8:15 PM CytomX Therapeutics Promotes Chris Ogden to Chief ... Source: CytomX Therapeutics Inc. May 22, 2024 @ 8:05 PM CytomX Therapeutics to Present at the Jefferies Gl... Source: CytomX Therapeutics Inc. May 16, 2024 @ 8:15 PM CytomX Therapeutics Announces New Employment Induc... Source: CytomX Therapeutics Inc. May 9, 2024 @ 6:59 PM Analysts' Varied Perspectives On CytomX's CX-904 C... Source: Vandana Singh May 8, 2024 @ 8:10 PM CytomX Therapeutics Reports First Quarter 2024 Fin... Source: CytomX Therapeutics Inc. Financials   TTM Q3 2024 Q4 2024 Basic EPS Diluted EPS Revenue $ 126.62M $ 33.43M $ 25.12M Gross Profit $ $ $ Net Income / Loss $ 13.83M $ 5.74M $ -6.53M Operating Income / Loss $ 6.71M $ 4.11M $ -8.45M Cost of Revenue $ $ $ Net Cash Flow $ 14.66M $ -2.56M $ 7.06M PE Ratio